Usage of silver nanoparticles to restore Moxifloxacin efficacy for fluoroquinolone-resistant M.tuberculosis cultures.

T Avaliani,N Kiria, N Bablishvili,N Kiria, G Phichkhaia

10.02 - Tuberculosis and non-tuberculous mycobacterial diseases(2022)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要